What changed since the last meeting
A comparison will appear when two board packs are available.
Each trust in this group reports its own performance and holds its own Oversight Framework segment.
Worcestershire Acute Hospitals NHS Trust
Oversight Framework segment 3 · Q1 2026/27
Performance at a glance
Latest published position to Aug 2026
| Measure | Latest | Standard | Change | Status | 12 month trend |
|---|---|---|---|---|---|
| A&E Wait Times, opens in a new tabAugust 2026 | Latest65.5% | Standard≥ 95% | Change−3.7 pts since Jul 2026 | StatusBelow standard. Below the 95% standard. | 12 month trend |
| Waiting times (RTT), opens in a new tabJuly 2026 | Latest61.7% | Standard≥ 92% | Change−1.2 pts since Jun 2026 | StatusBelow standard. Below the 92% standard. | 12 month trend |
| Diagnostic tests (DM01), opens in a new tabJuly 2026 | Latest69.4% | Standard≥ 99% | Change−2.0 pts since Jun 2026 | StatusBelow standard. Below the 99% standard. | 12 month trend |
| Cancer diagnosis (FDS), opens in a new tabJuly 2026 | Latest82.5% | Standard≥ 75% | Change−0.6 pts since Jun 2026 | StatusMeets standard. Meets the 75% standard. | 12 month trend |
| Cancer (31-day), opens in a new tabJuly 2026 | Latest87.0% | Standard≥ 96% | Change+0.6 pts since Jun 2026 | StatusBelow standard. Below the 96% standard. | 12 month trend |
| Cancer (62-day), opens in a new tabJuly 2026 | Latest53.0% | Standard≥ 85% | Change−4.0 pts since Jun 2026 | StatusBelow standard. Below the 85% standard. | 12 month trend |
Wye Valley NHS Trust
Oversight Framework segment 3 · Q1 2026/27
Performance at a glance
Latest published position to Aug 2026
| Measure | Latest | Standard | Change | Status | 12 month trend |
|---|---|---|---|---|---|
| A&E Wait Times, opens in a new tabAugust 2026 | Latest63.9% | Standard≥ 95% | Change−1.4 pts since Jul 2026 | StatusBelow standard. Below the 95% standard. | 12 month trend |
| Waiting times (RTT), opens in a new tabJuly 2026 | Latest63.3% | Standard≥ 92% | Change−0.5 pts since Jun 2026 | StatusBelow standard. Below the 92% standard. | 12 month trend |
| Diagnostic tests (DM01), opens in a new tabJuly 2026 | Latest80.3% | Standard≥ 99% | Change−1.2 pts since Jun 2026 | StatusBelow standard. Below the 99% standard. | 12 month trend |
| Cancer diagnosis (FDS), opens in a new tabJuly 2026 | Latest86.5% | Standard≥ 75% | ChangeLevel since Jun 2026 | StatusMeets standard. Meets the 75% standard. | 12 month trend |
| Cancer (31-day), opens in a new tabJuly 2026 | Latest96.3% | Standard≥ 96% | Change−0.5 pts since Jun 2026 | StatusMeets standard. Meets the 96% standard. | 12 month trend |
| Cancer (62-day), opens in a new tabJuly 2026 | Latest85.1% | Standard≥ 85% | Change−0.3 pts since Jun 2026 | StatusMeets standard. Meets the 85% standard. | 12 month trend |
Latest board intelligence
- Not recorded

Adam Carson

Ashi Williams

Dr Najam Rashid

Fiona Burton

Harkamal Heran

Ravi Basi

Robin Snead

Sophie Gilkes

Bharti Patel

Dr David Spraggett

Oli Hiscoe

Oliver Cofler

Paul Capener

Phil Gilbert

Umar Zamman
Photographs are shown from the organisation’s own website.
Foundation Group Strategy Committee
Other
These are the committees confirmed from the organisation’s own papers so far. We are confirming the rest.
- 7 October 2026 · Joint BoardPapers not yet published

